Industry: CBD pharmaceuticals
Cannabidiol (CBD) has shown enormous promise as a therapy for epilepsy, chronic pain, anxiety and other afflictions. However, the naturally occurring cannabinoid has properties that make it difficult to transfigure into a pharmaceutical product.
AgriThera is a pharmaceutical startup seeking solutions to that problem. The company is developing novel prodrugs that address the deficiencies in earlier applications of CBD. Their prodrugs improve pharmacokinetics and alter distribution in favor of brain penetration, bringing out the therapeutic properties of CBD in increasingly efficacious drugs.
Because CBD is an FDA-approved compound, drugs derived from it have a somewhat faster path to market.
Company website: AgriThera